Psychemedics Market Cap 2010-2024 | PMD

Psychemedics market cap history and chart from 2010 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Psychemedics market cap as of December 25, 2024 is $0B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $0.022B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.347B 0.00
Quest Diagnostics (DGX) United States $17.088B 17.32
DaVita (DVA) United States $12.452B 16.10
Encompass Health (EHC) United States $9.516B 22.43
Chemed (CHE) United States $7.874B 24.20
Elanco Animal Health (ELAN) United States $5.749B 13.68
RadNet (RDNT) United States $5.382B 119.18
Option Care Health (OPCH) United States $3.899B 18.48
LifeStance Health (LFST) United States $2.789B 0.00
Amedisys (AMED) United States $2.767B 19.69
Addus HomeCare (ADUS) United States $2.383B 27.96
Astrana Health (ASTH) United States $1.896B 25.92
U.S Physical Therapy (USPH) United States $1.378B 36.23
Pennant (PNTG) United States $0.940B 38.03
Aveanna Healthcare Holdings (AVAH) United States $0.885B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.040B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.006B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00